This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Merz, W G Articles by Sandford, G R Search for Related Content PubMed PubMed Citation Articles by Merz, W G Articles by Sandford, G R

 Previous Article  |  Next Article 

J Clin Microbiol. 1979 June; 9(6): 677-680

Isolation and characterization of a polyene-resistant variant of Candida tropicalis.

ABSTRACT

An atypical variant of Candida tropicalis was recovered from multiple specimens from a patient who had been a recipient of a bone marrow transplant. This yeast variant showed atypical morphology on corn meal agar distinguishable from typical isolates of C. tropicalis by the production of clusters of blastospores. Isolates of the variant produced acid, but no gas, from maltose and sucrose in fermentation tests. Isolates from blood, pleural fluid, respiratory secretions, and stool specimens were susceptible to amphotericin B and nystatin in an agar dilution system. However, eight isolates of the variant C. tropicalis recovered over a period of 4 weeks from the patient's urine after amphotericin B therapy were found to be resistant to amphotericin B and nystatin. The isolate recovered after 7 days of therapy had minimal inhibitory concentrations of 100 micrograms of amphotericin B and 20 micrograms of nystatin per ml, whereas the seven isolates recovered subsequently had minimal inhibitory concentrations of greater than 500 micrograms of amphotericin B and 50 micrograms of nystatin per ml. The resistant isolates concomitantly lost the capacity to utilize amino acids that susceptible isolates could utilize. Ultraviolet absorption spectra of nonsaponifiable fractions of whole cells showed that resistant isolates lacked ergosterol, which susceptible isolates contained.

This article has been cited by other articles:

• Francois, F., Noel, T., Pepin, R., Brulfert, A., Chastin, C., Favel, A., Villard, J. (2001). Alternative Identification Test Relying upon Sexual Reproductive Abilities of Candidalusitaniae Strains Isolated from Hospitalized Patients. J. Clin. Microbiol. 39: 3906-3914 [Abstract] [Full Text]  
• Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., Warnock, D. W. (2001). Antifungal Susceptibility Testing: Practical Aspects and Current Challenges. Clin. Microbiol. Rev. 14: 643-658 [Abstract] [Full Text]  
• Clancy, C. J., Nguyen, M. H. (1999). Correlation between In Vitro Susceptibility Determined by E Test and Response to Therapy with Amphotericin B: Results from a Multicenter Prospective Study of Candidemia. Antimicrob. Agents Chemother. 43: 1289-1290 [Abstract] [Full Text]  
• Davey, K. G., Holmes, A. D., Johnson, E. M., Szekely, A., Warnock, D. W. (1998). Comparative Evaluation of FUNGITEST and Broth Microdilution Methods for Antifungal Drug Susceptibility Testing of Candida Species and Cryptococcus neoformans. J. Clin. Microbiol. 36: 926-930 [Abstract] [Full Text]